[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Next100Baggers Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1760732748925263872.png) Next XXX Baggers [@Next100Baggers](/creator/twitter/Next100Baggers) on x 5739 followers
Created: 2025-07-22 20:35:16 UTC

$ISRG is priced for perfection. It’s sitting at roughly 75X LTM P/E and 59X EV/EBITDA, with forward P/E still north of 60X, compared to medtech peers that trade in the mid 20s to low 30s. That premium buys you:

- XX% CAGR in DaVinci installations since 2019
- XX% gross margins and high recurring procedure revenue
- 30%+ EPS growth over the last year

But at these multiples, any slip in growth, margin or procedure volume risks a swift multiple contraction. If you’re hunting for a better risk/reward, either wait for a 15–20% pullback or look at more moderately valued comparables (many peers sit around 15–20X EV/EBITDA).


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947757358051889660/c:line.svg)

**Related Topics**
[eps](/topic/eps)
[$isrg](/topic/$isrg)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/Next100Baggers/status/1947757358051889660)